![](/img/cover-not-exists.png)
698PA dose-response study of ramucirumab treatment in patients with gastric cancer/gastroesophageal junction adenocarcinoma: Primary results of 4 dosing regimens in the phase 2 trial I4T-MC-JVDB
Ajani, J.A., Udrea, A., Sarosiek, T., Shenker, M., Morgan, C., Pikiel, J., Wojcik, E., Swinson, D., Joseph, M., Luft, A., Salek, T., Tournigand, C., Ferry, D., Zhang, Y., Long, A., Kuo, W-L., Gao, L.,Volume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx369.082
Date:
September, 2017
File:
PDF, 53 KB
english, 2017